GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
Amid Election Clamor, Research Issues Surface
Sounds of Science Podcast
10 Takeover Targets of 2016
Which Biopharmas Do Wall Street Watchers View As Top Buyout Candidates?
Molecular Dx Has Your (Copy) Number
CNV Detection and Analysis Tools Are Being Used To Fill Genetic Diagnostic Gaps
Many people have taken to going overseas to receive alternative “stem cell” treatments, some of which have not been approved in the U.S. Anecdotes abound in which patients are cured of diseases that defy conventional medicine by these treatments. But the field also has numerous patients who have not recovered—or whose deaths followed expensive procedures.